Bausch + Lomb Corp
NYSE:BLCO

Watchlist Manager
Bausch + Lomb Corp Logo
Bausch + Lomb Corp
NYSE:BLCO
Watchlist
Price: 19.75 USD -0.05%
Market Cap: 7B USD
Have any thoughts about
Bausch + Lomb Corp?
Write Note

Profitability Summary

Bausch + Lomb Corp's profitability score is 46/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

46/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

46/100
Profitability
Score
46/100
Profitability
Score
High Profitability Stocks
Health Care Industry

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Bausch + Lomb Corp

Revenue
4.7B USD
Cost of Revenue
-1.8B USD
Gross Profit
2.9B USD
Operating Expenses
-2.7B USD
Operating Income
190m USD
Other Expenses
-558m USD
Net Income
-368m USD

Margins Comparison
Bausch + Lomb Corp Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CA
Bausch + Lomb Corp
NYSE:BLCO
7B USD
61%
4%
-8%
JP
Hoya Corp
TSE:7741
7T JPY
86%
28%
24%
CH
Alcon AG
SIX:ALC
37.8B CHF
55%
13%
11%
DK
Coloplast A/S
CSE:COLO B
205.9B DKK
68%
27%
19%
US
Align Technology Inc
NASDAQ:ALGN
16B USD
70%
17%
11%
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
53.9B CNY
73%
46%
42%
UK
ConvaTec Group PLC
LSE:CTEC
5.3B GBP
56%
13%
7%
CH
Ypsomed Holding AG
SIX:YPSN
5.2B CHF
34%
16%
14%
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.9B USD
47%
12%
9%
KR
HLB Inc
KOSDAQ:028300
8T KRW
11%
-306%
-472%
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.7B USD
65%
32%
29%
Country CA
Market Cap 7B USD
Gross Margin
61%
Operating Margin
4%
Net Margin
-8%
Country JP
Market Cap 7T JPY
Gross Margin
86%
Operating Margin
28%
Net Margin
24%
Country CH
Market Cap 37.8B CHF
Gross Margin
55%
Operating Margin
13%
Net Margin
11%
Country DK
Market Cap 205.9B DKK
Gross Margin
68%
Operating Margin
27%
Net Margin
19%
Country US
Market Cap 16B USD
Gross Margin
70%
Operating Margin
17%
Net Margin
11%
Country CN
Market Cap 53.9B CNY
Gross Margin
73%
Operating Margin
46%
Net Margin
42%
Country UK
Market Cap 5.3B GBP
Gross Margin
56%
Operating Margin
13%
Net Margin
7%
Country CH
Market Cap 5.2B CHF
Gross Margin
34%
Operating Margin
16%
Net Margin
14%
Country US
Market Cap 5.9B USD
Gross Margin
47%
Operating Margin
12%
Net Margin
9%
Country KR
Market Cap 8T KRW
Gross Margin
11%
Operating Margin
-306%
Net Margin
-472%
Country US
Market Cap 5.7B USD
Gross Margin
65%
Operating Margin
32%
Net Margin
29%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Bausch + Lomb Corp Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CA
Bausch + Lomb Corp
NYSE:BLCO
7B USD
-5%
-3%
2%
2%
JP
Hoya Corp
TSE:7741
7T JPY
20%
16%
22%
28%
CH
Alcon AG
SIX:ALC
37.8B CHF
5%
4%
5%
5%
DK
Coloplast A/S
CSE:COLO B
205.9B DKK
29%
11%
21%
13%
US
Align Technology Inc
NASDAQ:ALGN
16B USD
11%
7%
16%
9%
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
53.9B CNY
25%
23%
27%
38%
UK
ConvaTec Group PLC
LSE:CTEC
5.3B GBP
9%
4%
9%
7%
CH
Ypsomed Holding AG
SIX:YPSN
5.2B CHF
13%
8%
14%
9%
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.9B USD
9%
6%
8%
7%
KR
HLB Inc
KOSDAQ:028300
8T KRW
-38%
-25%
-19%
-19%
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.7B USD
46%
24%
36%
35%
Country CA
Market Cap 7B USD
ROE
-5%
ROA
-3%
ROCE
2%
ROIC
2%
Country JP
Market Cap 7T JPY
ROE
20%
ROA
16%
ROCE
22%
ROIC
28%
Country CH
Market Cap 37.8B CHF
ROE
5%
ROA
4%
ROCE
5%
ROIC
5%
Country DK
Market Cap 205.9B DKK
ROE
29%
ROA
11%
ROCE
21%
ROIC
13%
Country US
Market Cap 16B USD
ROE
11%
ROA
7%
ROCE
16%
ROIC
9%
Country CN
Market Cap 53.9B CNY
ROE
25%
ROA
23%
ROCE
27%
ROIC
38%
Country UK
Market Cap 5.3B GBP
ROE
9%
ROA
4%
ROCE
9%
ROIC
7%
Country CH
Market Cap 5.2B CHF
ROE
13%
ROA
8%
ROCE
14%
ROIC
9%
Country US
Market Cap 5.9B USD
ROE
9%
ROA
6%
ROCE
8%
ROIC
7%
Country KR
Market Cap 8T KRW
ROE
-38%
ROA
-25%
ROCE
-19%
ROIC
-19%
Country US
Market Cap 5.7B USD
ROE
46%
ROA
24%
ROCE
36%
ROIC
35%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top